Yull Arriaga

Yull Arriaga

UNVERIFIED PROFILE

Are you Yull Arriaga?   Register this Author

Register author
Yull Arriaga

Yull Arriaga

Publications by authors named "Yull Arriaga"

Are you Yull Arriaga?   Register this Author

21Publications

281Reads

8Profile Views

When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.

J Appl Lab Med 2019 Nov 2;4(3):446-450. Epub 2019 May 2.

Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/jalm.2018.027516DOI Listing
November 2019

Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial.

Target Oncol 2019 10;14(5):541-550

Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-019-00663-3DOI Listing
October 2019

Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases.

Clin Genitourin Cancer 2019 04 5;17(2):e263-e272. Epub 2018 Dec 5.

Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534272PMC
April 2019

Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

Pancreas 2019 01;48(1):e1-e3

Division of Endocrinology Department of Medicine The University of Arizona College of Medicine Tucson, AZ Division of Hematology/Oncology Department of Internal Medicine University of Texas Southwestern Medical Center Dallas, TX Division of Surgical Oncology Department of Surgery University of Texas Southwestern Medical Center Dallas, TX Department of Radiation Oncology University of Texas Southwestern Medical Center Dallas, TX Touchstone Diabetes Center Department of Internal Medicine University of Texas Southwestern Medical Center Dallas, TX Division of Hematology/Oncology Department of Internal Medicine University of Texas Southwestern Medical Center Dallas, TX

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00006676-201901000-0002
Publisher Site
http://dx.doi.org/10.1097/MPA.0000000000001208DOI Listing
January 2019

Unintended Consequences of Systemic and Ablative Oncologic Therapy in the Abdomen and Pelvis.

Radiographics 2018 Jul-Aug;38(4):1158-1179

From the Department of Radiology (J.C.B., G.K., L.M.W., J.R.L.) and Department of Internal Medicine, Division of Hematology/Oncology (Y.E.A.), University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2018170137DOI Listing
October 2018

Reply.

Urology 2018 02 6;112:111. Epub 2017 Dec 6.

Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.08.061DOI Listing
February 2018

Metastatic Giant Condyloma Acuminata (Buschke-Löwenstein Tumor).

J Oncol Pract 2016 10;12(10):951-953

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.013441DOI Listing
October 2016

Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition.

J Investig Med High Impact Case Rep 2014 Oct-Dec;2(4):2324709614560216. Epub 2014 Nov 23.

University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2324709614560216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528877PMC
October 2015

Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Can J Urol 2015 Aug;22(4):7865-75

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
August 2015

Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.

Cancer 2011 Jan 9;117(2):276-82. Epub 2010 Sep 9.

Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9110, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25429
Publisher Site
http://dx.doi.org/10.1002/cncr.25429DOI Listing
January 2011

Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.

BJU Int 2008 Jul 1;102(2):172-6. Epub 2008 Jul 1.

Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2008.07535.xDOI Listing
July 2008

Adverse effects of bevacizumab and their management in solid tumors.

Support Cancer Ther 2006 Jul;3(4):247-50

University of Texas Southwestern Medical School, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/SCT.2006.n.023DOI Listing
July 2006